Gene therapy to the blood-brain barrier with resulting protein secretion as a strategy for treatment of NPC2 disease

Standard

Gene therapy to the blood-brain barrier with resulting protein secretion as a strategy for treatment of NPC2 disease. / Hede, E.; Heegaard, C.; Körbelin, Jakob; Schwaninger, Markus; Moos, Torben; Burkhart, A.

in: HUM GENE THER, Jahrgang 2019, Nr. 30, 01.11.2019.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungKonferenz-Abstract in FachzeitschriftForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{ce76054ba9b84952944f12d8ddc0526c,
title = "Gene therapy to the blood-brain barrier with resulting protein secretion as a strategy for treatment of NPC2 disease",
author = "E. Hede and C. Heegaard and Jakob K{\"o}rbelin and Markus Schwaninger and Torben Moos and A. Burkhart",
year = "2019",
month = nov,
day = "1",
language = "English",
volume = "2019",
journal = "HUM GENE THER",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "30",

}

RIS

TY - JOUR

T1 - Gene therapy to the blood-brain barrier with resulting protein secretion as a strategy for treatment of NPC2 disease

AU - Hede, E.

AU - Heegaard, C.

AU - Körbelin, Jakob

AU - Schwaninger, Markus

AU - Moos, Torben

AU - Burkhart, A.

PY - 2019/11/1

Y1 - 2019/11/1

M3 - Conference abstract in journal

VL - 2019

JO - HUM GENE THER

JF - HUM GENE THER

SN - 1043-0342

IS - 30

ER -